Key facts
- Rofim’s last known valuation is $24.3M (Jul 2025).
- It has raised $16.7M; the latest was Later Stage VC ($10.9M) in Jul 2025.
- Notable investors include Google for Startups, Région Sud Investissement, Banque des Territoires, Axeltim, Buena Vista Capital — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Rofim
- ·The full record, as it builds
Funding rounds
No funding rounds for Rofim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rofim
Operator of a telemedicine platform intended for sharing clinical and patient-related data between doctors, clinics, and patients. The company's platform provides access to clinical description data and medical imaging in real-time, lets users connect to doctors and request health-related information, and features secure exchange and file-sharing tools, enabling doctors to organize and communicate health data and offer medical consultation to patients, anytime, and from any place.
- Sector
- Healthcare
- HQ
- Marseille, France
- Founded
- 2018
- Employees
- 30
- Website
- rofim.doctor/
- Ownership
- Privately Held (backing)
Rofim doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rofim shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rofim in its N-PORT filings yet. We sweep new filings monthly.